Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Hormone-refractory prostate cancer: Which Medications Cause It? (1,040 Reports Across 26 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Hormone-refractory prostate cancer has been reported as an adverse event with 26 different drugs in the FDA's FAERS database, with 1,040 total reports. 290 of these reports resulted in death.The drugs most commonly associated with Hormone-refractory prostate cancer are RADIUM RA-223 DICHLORIDE, LEUPROLIDE, and DOCETAXEL.

1,040
Total Reports
26
Drugs Involved
290
Deaths
130
Hospitalizations
73.2 yrs
Average Patient Age
0.0% / 100.0%
Female / Male

Which Drugs Cause Hormone-refractory prostate cancer Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
RADIUM RA-223 DICHLORIDE 441 9.2% 154 66 11
LEUPROLIDE 180 0.3% 30 19 1
DOCETAXEL 123 0.2% 4 5 0
ENZALUTAMIDE 120 0.2% 30 6 0
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 110 1.0% 40 19 0
DAROLUTAMIDE 104 3.2% 9 4 0
ABIRATERONE 83 0.2% 6 5 0
PREDNISONE 58 0.0% 7 5 0
CABAZITAXEL 57 2.2% 2 4 0
BICALUTAMIDE 50 1.2% 0 3 0
CARBOPLATIN 27 0.0% 0 1 0
DENOSUMAB 26 0.0% 11 3 1
OLAPARIB 22 0.1% 0 0 0
ZOLEDRONIC ACID 22 0.1% 6 2 0
DEGARELIX 17 0.5% 4 1 0
SIPULEUCEL-T 10 0.2% 0 0 0
APALUTAMIDE 9 0.1% 2 2 1
DOCETAXEL\DOCETAXEL ANHYDROUS 9 0.2% 1 0 0
FILGRASTIM 8 0.1% 5 0 2
GOSERELIN 8 0.1% 3 0 0

View all 26 drugs →

Top 3 Drugs Associated With Hormone-refractory prostate cancer

180 reports
123 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)